Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -5.86 |
| peg ratio | -1.50 |
| price to book ratio | 1.65 |
| price to sales ratio | 19.93 |
| enterprise value multiple | -0.76 |
| price fair value | 1.65 |
profitability ratios | |
|---|---|
| gross profit margin | 85.2% |
| operating profit margin | -618.81% |
| pretax profit margin | -398.61% |
| net profit margin | -400.65% |
| return on assets | -9.41% |
| return on equity | -32.51% |
| return on capital employed | -17.38% |
liquidity ratio | |
|---|---|
| current ratio | 4.89 |
| quick ratio | 4.80 |
| cash ratio | 3.33 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 1,441.72 |
| operating cycle | 1,051.07 |
| days of payables outstanding | 5,057.52 |
| cash conversion cycle | -4,006.45 |
| receivables turnover | -0.93 |
| payables turnover | 0.07 |
| inventory turnover | 0.25 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | 1.31 |
| long term debt to capitalization | 0.56 |
| total debt to capitalization | 0.57 |
| interest coverage | -3.10 |
| cash flow to debt ratio | -1.61 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.63 |
| cash per share | 0.67 |
| operating cash flow per share | -0.63 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.61 |
| short term coverage ratios | -102.83 |
| capital expenditure coverage ratio | -392.67 |
Frequently Asked Questions
X4 Pharmaceuticals, Inc. (XFOR) published its most recent earnings results on 13-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. X4 Pharmaceuticals, Inc. (NASDAQ:XFOR)'s trailing twelve months ROE is -32.51%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. X4 Pharmaceuticals, Inc. (XFOR) currently has a ROA of -9.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
XFOR reported a profit margin of -400.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.89 in the most recent quarter. The quick ratio stood at 4.80, with a Debt/Eq ratio of 1.31.